Dr Paul Young describes MEGA-ROX, a registry-based, adaptive platform trial investigating oxygenation targets in the critically ill. This is followed by a panel discussion involving trialists, methodologists and statisticians on this ambitious trial design.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Critical Care Reviews Podcast","authorlink":""},"src":"https:\/\/traffic.libsyn.com\/secure\/ccrpodcast\/CCR20-MEGA-ROX.mp3?dest-id=316836","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202309\/f5f2b5-1d86-ae0f-2fae30_800.png"},"title":"MEGA-ROX","link":"javascript:;","id":"item-692907"}]